secwatch.observer — SEC 8-K summary
======================================

Issuer:     TACTILE SYSTEMS TECHNOLOGY INC (TCMD)
CIK:        0001027838
Form:       8-K
Filed at:   2022-02-22T23:59:59+00:00
Accession:  0001558370-22-001579
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tactile Medical Q4 rev $61.7M (+4% YoY); net loss $7.5M; FY 2022 guidance $235-240M
--------------------------------------------------------------------------------

- Q4 revenue $61.7M (+4% YoY); full year 2021 revenue $208.1M (+11% YoY).
- Q4 net loss $7.5M ($0.38 loss per share) vs net income $12.1M ($0.61 EPS) in Q4 2020.
- Adjusted EBITDA Q4 $9.5M vs $10.8M prior year; full year $17.7M vs $16.0M.
- FY 2022 revenue guidance $235-240M (13-15% growth) with Omicron and staffing headwinds expected in H1.
- Qui tam lawsuit dismissed with no damages; board appointed Valerie Asbury and D. Brent Shafer in Jan 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1027838/000155837022001579/0001558370-22-001579-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1027838/000155837022001579/tcmd-20220222x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-001579

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer